COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > Perplexity Ai's suggested pricing, margin, and marketing

<< Previous

Bullboard Posts

Next >>

Post by prophetoffactzon Sep 08, 2024 11:20am

167 Views

Post# 36213766

Perplexity Ai's suggested pricing, margin, and marketing

Based on the information provided, here is a suggested pricing, margin, and marketing strategy for Cosciens Biopharma's programs:

Pricing Strategy

Oat Beta Glucan Chewable

Premium pricing to reflect the product's unique formulation and health benefits
Initial price point of $29.99-$39.99 for a 30-day supply
Subscription model offering 10-15% discount for recurring orders

Avenanthramides Nutraceutical

Mid-range pricing of $24.99-$34.99 for a 30-day supply
Tiered pricing based on dosage strength (low vs high dose options)

Yeast Beta Glucan Capsules

Competitive pricing of $19.99-$29.99 for a 30-day supply
Bulk purchase discounts to encourage larger orders

Margin Strategy

Target gross profit margins of 60-70% across all product lines
Focus on efficient manufacturing and economies of scale to improve margins over time
Explore direct-to-consumer sales channels to maximize profit potential

Marketing Strategy

Key Messages:

Science-backed formulations with proven health benefits
Unique extraction and purification technologies
Convenient delivery formats (chewables, capsules)

Channels:

E-commerce platforms as the primary sales channel
Social media marketing to build brand awareness
Partnerships with health/wellness influencers and bloggers
Content marketing highlighting clinical studies and product benefits

Tactics:

Free samples with first purchase to encourage trial
Loyalty program to incentivize repeat purchases
Educational content on cholesterol reduction, inflammation, and immune health
Targeted ads to health-conscious consumers and those with specific health concerns

Launch Plan:

Soft launch of Oat Beta Glucan chewable in H2 2024 leveraging Health Canada approval
Gradual rollout of additional products in 2025
Focus on building brand recognition and establishing market presence

By implementing this strategy, Cosciens Biopharma can position its nutraceutical products as premium, science-backed solutions while maximizing profitability and market penetration. The company should regularly review and adjust pricing and marketing tactics based on market response and competitive landscape.